RTVue XR OCT Avanti 配合 AngioVue 軟體
K 號：K153080 · 2016-02-11
廣告
決定日期2016-02-11
產品代碼HLI
諮詢委員會此為醫療器材法規文本之翻譯。根據醫療法規翻譯政策，以下為繁體中文譯文：
本文件概述適用於醫療器材之監管架構，包括美國食品藥物管理局（FDA）之上市前審查程序。第510(k)條途徑適用於與已合法上市器材（predicate device）實質等效之器材，而上市前核准（PMA）則為最高風險等級（Class III）器材所要求。臨床證據可能引用NCT編號之試驗登記，或PMID編號之同行評審文獻。所有產品名稱、公司名稱、識別碼及統一資源定位符（URL）均保留原文，以確保可追溯性及法規提交之完整性。
決定相當於
器材摘要
RTVue XR OCT Avanti with AngioVue Software is the device name listed in this FDA 510(k) record. The listed applicant is Optovue, Inc.. It received FDA 510(k) clearance on 2016-02-11 under 510(k) number K153080. The device is classified under product code HLI. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.
常見問題
What is the RTVue XR OCT Avanti with AngioVue Software?
RTVue XR OCT Avanti with AngioVue Software is a medical device that received FDA 510(k) clearance on 2016-02-11. The listed applicant is Optovue, Inc.. The 510(k) number is K153080.
When did RTVue XR OCT Avanti with AngioVue Software receive FDA 510(k) clearance?
RTVue XR OCT Avanti with AngioVue Software received FDA 510(k) clearance on 2016-02-11, under 510(k) number K153080.
Who is the listed applicant for RTVue XR OCT Avanti with AngioVue Software?
The FDA 510(k) record lists Optovue, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for RTVue XR OCT Avanti with AngioVue Software?
The FDA product code for RTVue XR OCT Avanti with AngioVue Software is HLI.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
其他以 Optovue, Inc. 為申請人之記錄
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告